These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32249022)

  • 1. Symptomatic joint hypermobility.
    Tinkle BT
    Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101508. PubMed ID: 32249022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT; Levy HP
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.
    Colombi M; Dordoni C; Chiarelli N; Ritelli M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):6-22. PubMed ID: 25821090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint hypermobility and headache: understanding the glue that binds the two together--part 1.
    Neilson D; Martin VT
    Headache; 2014 Sep; 54(8):1393-402. PubMed ID: 25040892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
    Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
    Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric joint hypermobility: a diagnostic framework and narrative review.
    Tofts LJ; Simmonds J; Schwartz SB; Richheimer RM; O'Connor C; Elias E; Engelbert R; Cleary K; Tinkle BT; Kline AD; Hakim AJ; van Rossum MAJ; Pacey V
    Orphanet J Rare Dis; 2023 May; 18(1):104. PubMed ID: 37143135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric generalized joint hypermobility with and without musculoskeletal complaints: a localized or systemic disorder?
    Engelbert RH; Bank RA; Sakkers RJ; Helders PJ; Beemer FA; Uiterwaal CS
    Pediatrics; 2003 Mar; 111(3):e248-54. PubMed ID: 12612280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining patterns of joint hypermobility, habitus, and orthopedic traits in joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type.
    Morlino S; Dordoni C; Sperduti I; Venturini M; Celletti C; Camerota F; Colombi M; Castori M
    Am J Med Genet A; 2017 Apr; 173(4):914-929. PubMed ID: 28266107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary approach to joint hypermobility and related disorders.
    Castori M; Hakim A
    Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masterclass: Hypermobility and hypermobility related disorders.
    Simmonds JV
    Musculoskelet Sci Pract; 2022 Feb; 57():102465. PubMed ID: 34808594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized joint hypermobility and temporomandibular disorders: inherited connective tissue disease as a model with maximum expression.
    De Coster PJ; Van den Berghe LI; Martens LC
    J Orofac Pain; 2005; 19(1):47-57. PubMed ID: 15779539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
    Micale L; Fusco C; Castori M
    Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome.
    Remvig L; Flycht L; Christensen KB; Juul-Kristensen B
    Am J Med Genet A; 2014 Mar; 164A(3):591-6. PubMed ID: 24464988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beighton Score as a measure of generalised joint hypermobility.
    Malek S; Reinhold EJ; Pearce GS
    Rheumatol Int; 2021 Oct; 41(10):1707-1716. PubMed ID: 33738549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: A review for the gastroenterologist.
    Beckers AB; Keszthelyi D; Fikree A; Vork L; Masclee A; Farmer AD; Aziz Q
    Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28086259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
    Peterson B; Coda A; Pacey V; Hawke F
    J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint hypermobility in children: a neglected sign needing more attention.
    Castori M
    Minerva Pediatr; 2020 Apr; 72(2):123-133. PubMed ID: 32274910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between adult attention-deficit hyperactivity disorder and generalised joint hypermobility: A cross-sectional case control comparison.
    Glans M; Thelin N; Humble MB; Elwin M; Bejerot S
    J Psychiatr Res; 2021 Nov; 143():334-340. PubMed ID: 34560594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised.
    Sinibaldi L; Ursini G; Castori M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):97-106. PubMed ID: 25821094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.